MedPath

Smart Device-based Cardiac Rehabilitation After Myocardial Intervention

Not Applicable
Completed
Conditions
Myocardial Infarction
Interventions
Device: Smart device-based cardiac rehabilitation
Registration Number
NCT03926312
Lead Sponsor
Charles University, Czech Republic
Brief Summary

The aim of this study is to evaluate the influence of cardiac rehabilitation based on smart band use and telemonitoring on functional capacity change and risk factors control among patients hospitalized for acute myocardial infarction.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  1. Signed informed consent with the study
  2. Men and women >18 years of age
  3. Patients ≥1 and ≤6 months after type I myocardial infarction
  4. Physical inactivity before MI defined as the absence of moderate to vigorous exercise for at least 30 minutes 5 or more days a week
Exclusion Criteria
  1. Heart failure NYHA IIIB-IV
  2. Planned coronary revascularization
  3. Planned major surgery within the next 12 months
  4. Inability to walk for any reason
  5. Comorbidities that would preclude adherence to the rehabilitation program (e.g. arthrosis, active malignancy, major depression or other significant psychiatric disorder, cognitive impairment) - at the discretion of the physician
  6. Life expectancy less than 12 months
  7. Pregnancy
  8. Inability to operate the smart-watch

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Smart device-based rehabilitationSmart device-based cardiac rehabilitationOne month after myocardial infarction, patients will receive a smart band and a cellphone in order to transmit data on physical activity to electronic health record. A study nurse will periodically check compliance with recommended physical activity and intervene in the case of non-compliance.
Primary Outcome Measures
NameTimeMethod
Functional capacity change3 months

6-minute walk test distance and maximal oxygen consumption (VO2 max) change after 3 months of the intervention

Secondary Outcome Measures
NameTimeMethod
Body fat percentage3 months

Body fat percentage change after 3 months of the intervention

Waist circumference3 months

Waist circumference change after 3 months of the intervention

Blood pressure3 months

Blood pressure change after 3 months of the intervention

Smoking cessation3 months

Smoking cessation after 3 months of the intervention

Lipid levels3 months

Lipid levels change after 3 months of the intervention

Glycated hemoglobin3 months

Glycated hemoglobin change after 3 months of the intervention

Trial Locations

Locations (1)

Institute for Clinical and Experimental Medicine

🇨🇿

Prague, CZEC, Czechia

© Copyright 2025. All Rights Reserved by MedPath